Consensus Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 04:00:02 2024-05-03 pm EDT			5-day change	1st Jan Change
735 ^USD	-2.77%		+0.20%	+26.08%

May. 03	News Highlights : Top Company News of the Day - Friday at 5 PM ET	DJ
May. 03	News Highlights : Top Company News of the Day - Friday at 7 PM ET	DJ

Evolution of the average Target Price on Eli Lilly and Company

Price target over the last 5 years

History of analyst recommendation changes

58fd8972416a3b2f34525de482.GQP64QXoFeubgJ51e_otpoiiqK40KAHQQbZDjS-QOI4.X23CkFCuXd7I6dQAL8J79fv4zs1ZQ2qzKcEa7mD-Qdpzc7PZattzr-_56Q~42cd8c60da6b547da5baca7e121befc4

Analyst Recommendations on Eli Lilly and Company

JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850	May. 01	MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813	May. 01	MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810	May. 01	MT
BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900	May. 01	MT
Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821	May. 01	MT
Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695	May. 01	MT
Truist Raises Price Target on Eli Lilly to $892 From $850, Keeps Buy Rating	May. 01	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723	May. 01	MT
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825	May. 01	MT
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating	May. 01	MT
Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating	Apr. 30	MT
Jefferies Raises Eli Lilly's Price Target to $895 From $885, Buy Rating Kept	Apr. 17	MT
BMO Raises Price Target on Eli Lilly to $900 From $865	Apr. 12	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
Goldman Sachs Raises Price Target on Eli Lilly to $723 From $650, Maintains Neutral Rating	Apr. 11	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman...	Apr. 02
Top Midday Stories: Bankman-Fried Gets 25-Year Prison Sentence; Home Depot Acquiring SRS Distribution; Walgreens Lowers FY 2024 Outlook; Analyst Says Short MicroStrategy; Canadian School Boards Sue Social Media Platforms; Eli Lilly Weight-Loss Drug Facing Shortage	Mar. 28	MT
JPMorgan Raises Eli Lilly's Price Target to $850 From $775, Maintains Overweight Rating	Mar. 15	MT
UBS Adjusts Eli Lilly Price Target to $910 From $810, Maintains Buy Rating	Mar. 04	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
BofA Securities Hikes Price Target on Eli Lilly to $1,000 From $800 Citing Tirzepatid Label Expansion, Keeps Buy Rating	Mar. 01	MT
ANALYST RECOMMENDATIONS : Domino's pizza, WPP, PPG, Workday, Eli Lilly...	Feb. 27
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
DZ Bank Downgrades Eli Lilly to Hold From Buy, Raises Price Target to $820 From $790	Feb. 21	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

735 USD

Average target price

848.3 USD

Spread / Average Target

+15.43%

High Price Target

1,023 USD

Spread / Highest target

+39.19%

Low Price Target

540 USD

Spread / Lowest Target

-26.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eli Lilly and Company

JPMorgan Chase
Wolfe Research
Barclays
BMO Capital
Leerink Partners
Deutsche Bank Securities
Truist Securities
Goldman Sachs
Wells Fargo Securities
Morgan Stanley
Jefferies & Co.
UBS
BofA Securities
DZ Bank
JEFFERIES	Akash Tewari
Cantor Fitzgerald
Morningstar
Guggenheim
Daiwa Securities
Berenberg Bank
Citigroup
Argus
Credit Suisse
HSBC
TD Cowen
SVB Securities LLC
Cowen
Mizuho Securities

Ratings for Eli Lilly and Company

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar